TradingMarkets’ 10 Stocks You Need To Know About Today

AmerisourceBergen
(
ABC |
Quote |
Chart |
News |
PowerRating)
lowered Q2 and ’05 guidance by a wide
margin. Trading down in sympathy pre-open: Cardinal Health
(
CAH |
Quote |
Chart |
News |
PowerRating)
and
McKesson

(
MCK |
Quote |
Chart |
News |
PowerRating)
.

The Wall Street Journal reports that 12 AIG executives have
been subpoenaed

Barron’s said Tiffany
(
TIF |
Quote |
Chart |
News |
PowerRating)
could be worth as much as $40 to $60
on a takeover basis or at least $40 if management can fix the company’s
problems.

The FDA approved GlaxoSmithKline’s
(
GSK |
Quote |
Chart |
News |
PowerRating)
once-per-month Boniva
osteoporosis drug.

Millenium Pharmaceuticals
(
MLNM |
Quote |
Chart |
News |
PowerRating)
said the FDA granted expanded
approval for its cancer drug Velcade.

Ligand’s
(
LGND |
Quote |
Chart |
News |
PowerRating)
cancer treatment disappointed.

UBS downgraded General Motors
(
GM |
Quote |
Chart |
News |
PowerRating)
  to ‘reduce.’

Morgan Keegan cut estimates on Taser
(
TASR |
Quote |
Chart |
News |
PowerRating)
for 2005 and 2006.